Literature DB >> 3223876

Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57.

G Heusch1, S Schäfer, K Kröger.   

Abstract

Contractile dysfunction of reversibly injured, reperfused myocardium can be enhanced by inotropic interventions. A decrease in the Ca-sensitivity of contractile proteins with slow recovery during reperfusion has been suggested as a potential mechanism underlying this postischemic dysfunction. We therefore tested the effects of the cardiotonic agent AR-L 57 (1 mg/kg i.v.) in six anesthetized, vagotomized dogs during constant atrial pacing at 192 +/- 6 beats/min. Before ischemia, AR-L 57 increased left ventricular pressure from 131 +/- 22 to 138 +/- 21 mm Hg and maximum dP/dt from 3,022 +/- 1,427 to 4,337 +/- 2,608 mm Hg/s. Mean systolic thickening velocity of the posterior myocardium was increased from 8.9 +/- 1.1 to 11.7 +/- 1.1 mm/s. After release of a 15 min LCX-occlusion which caused complete regional akinesia, baseline function in the posterior myocardium was severely depressed and only gradually returned towards control values over 8 h of reperfusion. AR-L 57 increased systolic thickening velocity at 10 min, 4 and 8 h reperfusion to a similar extent as before ischemia. With reference to a purported Ca-sensitizing mechanism underlying the positive inotropic action of AR-L 57, our data suggest no change in the Ca-sensitivity of reperfused myocardium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3223876     DOI: 10.1007/bf01906954

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  40 in total

1.  Investigation of the pharmacodynamics and pharmacokinetics of 2-(2,4-dimethoxyphenyl)-Imidazo-(4,5-b)-pyridine hydrochloride (AR-L 57 CL) in man.

Authors:  G G Belz; H Nübling; A Zimmer
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

2.  Coronary arterial reperfusion. III. Early and late effects on regional myocardial function and dimensions in conscious dogs.

Authors:  P Theroux; J Ross; D Franklin; W S Kemper; S Sasayama
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

3.  Inhibition of the sodium pump in squid axons by the cardioactive drug AR-L 57.

Authors:  P Honerjäger; M Reiter; P F Baker
Journal:  Mol Pharmacol       Date:  1980-05       Impact factor: 4.436

4.  Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration.

Authors:  R Bolli; W X Zhu; M L Myers; C J Hartley; R Roberts
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

5.  Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.

Authors:  W Diederen; R Kadatz
Journal:  Arzneimittelforschung       Date:  1981

6.  End-systolic dimension-wall thickness relations during myocardial ischemia in conscious dogs. A new approach for defining regional function.

Authors:  G Osakada; O M Hess; K P Gallagher; W S Kemper; J Ross
Journal:  Am J Cardiol       Date:  1983-06       Impact factor: 2.778

7.  Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog.

Authors:  J L Swain; R L Sabina; P A McHale; J C Greenfield; E W Holmes
Journal:  Am J Physiol       Date:  1982-05

8.  Phosphodiesterase-inhibiting properties of newer inotropic agents.

Authors:  H Scholz; W Meyer
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

9.  Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies.

Authors:  K A Reimer; R B Jennings; A H Tatum
Journal:  Am J Cardiol       Date:  1983-07-20       Impact factor: 2.778

10.  Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis.

Authors:  L W DeBoer; J S Ingwall; R A Kloner; E Braunwald
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  10 in total

1.  Recruitment of a time-dependent inotropic reserve by postextrasystolic potentiation in normal and reperfused myocardium.

Authors:  S Schäfer; G Heusch
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

2.  Improved ventricular function by enhancing the Ca++ sensitivity in normal and stunned myocardium of isolated rabbit hearts.

Authors:  B Korbmacher; U Sunderdiek; G Arnold; H D Schulte; J D Schipke
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

3.  Phosphorylation by protein kinase C and the responsiveness of Mg(2+)-ATPase to Ca2+ of myofibrils isolated from stunned and non-stunned porcine myocardium.

Authors:  K Bezstarosti; L K Soei; P D Verdouw; J M Lamers
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.

Authors:  S Schäfer; C Linder; G Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 5.  Stunning: a radical re-view.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 6.  Clinical relevance of myocardial "stunning".

Authors:  R Bolli; C J Hartley; R S Rabinovitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 7.  Oxygen-derived free radicals and myocardial reperfusion injury: an overview.

Authors:  R Bolli
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

Review 8.  Novel mechanisms mediating stunned myocardium.

Authors:  Song-Jung Kim; Christophe Depre; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 9.  Hibernating, stunning and ischemic preconditioning of the myocardium: therapeutic implications.

Authors:  F Niroomand; W Kübler
Journal:  Clin Investig       Date:  1994-10

Review 10.  Myocardial stunning and hibernation revisited.

Authors:  Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-02-02       Impact factor: 32.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.